ARA-290 (Cibinetide) is a synthetic 11-amino acid peptide modeled on the helix B surface domain of Erythropoietin (EPO)
There is no official clinical guidance on combining these treatments, as Lipo C formulations are unapproved compounded products not reviewed by the FDA
For single-session in-vitro work, sterile saline is acceptable
This 15-amino acid fragment is also frequently referred to as Body Protection Compound (BPC)
In both mouse and human cells, the researchers showed that the plant-derived drug caused a variety of cell types, including oral-tissue cells and osteoblasts, or bone-building cells, to grow and differentiate, or divide to form a variety of different cell types
It is available as a research peptide and is also found in some cosmetic formulations